Syreon is a leading technology-driven Contract Research Organization (CRO) combining elite biomedical sciences, advanced information technologies and global clinical trial networks to speed the evaluation of new drugs, diagnostics and medical devices and guide safe, effective and cost-efficient clinical use.
Syreon partners primarily with leading global pharmaceutical corporations, emerging biotechnology companies and academic networks to carry-out comprehensive health sciences research programs ranging from biomarker development and formal clinical trials to longitudinal disease-based registry studies and health economic / outcomes research in a broad range of therapeutic fields. The majority of our clients represent companies with offices in USA, Canada, UK, continental Europe, Middle East, South Africa, and parts of South America and Australasia. Our top 5 clients are all major top 10 global pharma corporations, each representing approximately 15% of our aggregate turnover.
Syreon streamlines site management, drawing on our international networks of expert academic and community investigators to ensure rapid commitment, contracting, IRB approval, training and set-up, with continuous support to speed the learning curve, improve protocol adherence and data accuracy, and minimize time and costs.
Expert project managers work closely with each sponsor to identify precise objectives, timelines and outcomes; support trial committees; track communications, timelines, milestones and operations; and ensure that studies are conducted on time, within budget, and in accordance with all relevant regulatory guidelines.
Our expert editorial team provides all study documents, clinical reports, conference presentations and manuscripts, coordinating rigorous review by investigators, and enabling the results of the research study to be presented and published quickly in high-profile scientific journals.
Enjoy complete support for all trials from clinical trial design to project simulation, data visualization and modeling, interim and formal trial analysis, DSMB support, and presentation of results to regulatory agencies and other bodies with a full complement of pharmacokinetic, dynamic, genomic, clinical and economic analyses.
Syreon offers flexible integration of all forms of data input via its sophisticated and 21CFR part 11 fully compliant ClinStream EDC and ePRO systems. These provide full capabilities from direct single-point entry to the automated upload, processing, integration and on-line analysis of complex multidimensional institutional data.
Select full or risk-based strategies for clinical monitoring to ensure efficient trial management and high data quality. Incorporate sophisticated data-driven strategies to identify site risks, performance failures, and potential trial hazards in advance to ensure optimal quality and safety at lowest cost.
Syreon Corporation has not received any reviews.
Syreon Corporation has not received any endorsements.